Not found

Edward A. Graviss, PhD, MPH

Associate Professor of Pathology and Genomic Medicine, Institute for Academic Medicine
Associate Member, Research Institute
Houston Methodist


Research Lab


eagraviss@houstonmethodist.org
Biography

After receiving his doctoral degree in Epidemiology from The University of Texas Health Science Center at Houston, School of Public Health in 1993, Dr. Graviss joined the Michael DeBakey Houston VA Medical Center in Houston as an infectious disease epidemiologist, a position he still holds. He became a Research Instructor of Medicine at Baylor College of Medicine in 1994, and was later promoted to dual Associate Professorships there in the Departments of Pathology and Medicine in the section of Infectious Diseases, where he still holds adjunct positions. Dr. Graviss joined the Center for Molecular and Translational Human Infectious Diseases Research in the Houston Methodist Research Institute in 2008. Dr. Graviss holds several other joint adjunct positions including; Associate Professorships at the UT School of Public Health and the Division of the Health Sciences, the School of Biotechnology, and Health Tecnolóico de Monterrey, Monterrey, Mexico.

 

Description of Research

Dr. Graviss has extensive expertise in the study of the epidemiology and population-based surveillance of a variety of infectious agents including Mycobacterium tuberculosis. His recent studies focus on evaluation of the new Interferon Gamma Release Assays (IGRAs) in the diagnosis of latent tuberculosis infection.

Areas Of Expertise

Infectious agents Mycobacterium tuberculosis Latent tuberculosis
Education & Training

PhD, University of Texas Health Science Center
MPH, The University of Texas Health Science Center
MS, University of Texas San Antonio
BS, Texas Tech. University
Publications

Tuberculosis Transmission in Households and Classrooms of Adolescent Cases Compared to the Community in China
Pan, D, Lin, M, Lan, R, Graviss, EA, Lin, D, Liang, D, Long, X, Qin, H, Huang, L, Huang, M & Chongsuvivatwong, V 2018, International Journal of Environmental Research and Public Health, vol. 15, no. 12. DOI: 10.3390/ijerph15122803

Phlebotomy Methods May Affect QuantiFERON Gold Plus Assay Results
Agarwal, S, Nguyen, DT, Lew, JD & Graviss, EA 2018, Annals of the American Thoracic Society. DOI: 10.1513/AnnalsATS.201804-239RL

Risk factors for extrapulmonary dissemination of tuberculosis and associated mortality during treatment for extrapulmonary tuberculosis article
Qian, X, Nguyen, DT, Lyu, J, Albers, AE, Bi, X & Graviss, EA 2018, Emerging Microbes and Infections, vol. 7, no. 1, 102. DOI: 10.1038/s41426-018-0106-1

Performance and variability of QuantiFERON Gold Plus assay associated with phlebotomy type
Agarwal, S, Nguyen, DT, Lew, JD & Graviss, EA 2018, PloS one, vol. 13, no. 11, e0207892, pp. e0207892. DOI: 10.1371/journal.pone.0207892

Morbidity Trends and Associated Characteristics in Multi-drug Resistant and Extensively Drug Resistant Tuberculosis in Texas, 2010-2017
Nguyen, DT & Graviss, EA 2018, End TB 2019: 23rd Annual Conference of The Union-North America Region, Vancouver, Canada, 2/21/19 - 2/23/19, .

Pre-Transplant Serum Chemokines As Biomarkers for Prediction of Futility Following Liver Transplantation in High Acuity Recipients
Lunsford, KE, Moore, LW, Nguyen, DTM, Graviss, EA, Manner, CJ, Vyas, H, Thomas, JV, Minze, LJ, Dorman, SA, Saharia, A, Mobley, CM, Hobeika, MJ, Victor, III, DW, McFadden, RS, Gaber, AO, Li, XC & Ghobrial, RM 2018, American Association for the study of Liver Diseases - AASLD 2018, San Francisco, United States, 11/9/18 - 11/13/18, .

Survival and Recidivism in Patients Undergoing Early Liver Transplant for Acute Alcoholic Hepatitis: A Single Center Analysis
Thomas, JV, Lunsford, KE, Victor, III, DW, Theriot, L, Ontiveros, J, Nguyen, DTM, Graviss, EA, Saharia, A, Mobley, CM, Hobeika, MJ, Corkrean, J, Balogh, J, Galati, J, Ankoma-Sey, V, Egwim, C, Duchini, A, Li, XC, McFadden, RS, Monsour, Jr. HP, Gaber, AO & Ghobrial, RM 2018, American Association for the study of Liver Diseases - AASLD 2018, San Francisco, United States, 11/9/18 - 11/13/18, .

Retransplantation Outcomes at a Large Lung Transplantation Program
Ren, D, Kaleekal, TS, Graviss, EA, Nguyen, DT, Sinha, N, Goodarzi, A, Agboli, I, Suarez, EE, Loebe, M, Scheinin, SA & Bruckner, BA 2018, Transplantation Direct, vol. Online Now. DOI: 10.1097/TXD.0000000000000844

Evaluating an Education Program to Reduce Indeterminate QuantiFERON Gold In-Tube Results
Agarwal, S, Nguyen, DT, Lew, JD, Campbell, B & Graviss, EA 2018, Tuberculosis research and treatment, vol. 2018, 7906846. DOI: 10.1155/2018/7906846

Risk Factors for Homeless Status and Mortality among Homeless TB Cases in Texas, 2010-2017
Agarwal, S, Nguyen, DTM & Graviss, EA 2018, IDSA IDWeek 2018, San Francisco, United States, 10/3/18 - 10/7/18, .

Trend of tuberculosis meningitis and associated mortality in Texas, 2010-2017, a large population-based analysis
Nguyen, DTM, Agarwal, S & Graviss, EA 2018, IDSA IDWeek 2018, San Francisco, United States, 10/3/18 - 10/7/18, .

Adolescent Tuberculosis Associated with Tuberculosis Exposure in Classrooms and Dorm Rooms in Guangxi, China
Pan, D, Lan, R, Graviss, EA, Lin, D, Liang, D, McNeil, E, Lin, M & Chongsuvivatwong, V 2018, International Journal of Infectious Diseases. DOI: 10.1016/j.ijid.2018.09.019

Change in QTC Interval after Kidney Transplantation; Mechanisms and Outcomes
Lai, E, Acharya, V, Nguyen, DTM, Graviss, EA, Gaber, AO & Suki, WN 2018, Experimental and Clinical Transplantation, vol. 3, no. 121. DOI: 10.4172/2475-7640.1000121

Suitability of Estimated Glomerular Filtration Rate for Live Kidney Donor Selection
Akhimiona, CO, Nguyen, DT, Graviss, EA, Gaber, AO & Suki, WN 2018, Transplantation Proceedings. DOI: 10.1016/j.transproceed.2018.09.013

Chlorhexidine bathing and Clostridium difficile infection in a surgical intensive care unit
Bui, LN, Swan, JT, Shirkey, BA, Olsen, RJ, Long, SW & Graviss, EA 2018, The Journal of surgical research, vol. 228, pp. 107-111. DOI: 10.1016/j.jss.2018.02.063

Schistosomiasis Induces Persistent DNA Methylation and Tuberculosis-Specific Immune Changes
DiNardo, AR, Nishiguchi, T, Mace, EM, Rajapakshe, K, Mtetwa, G, Kay, A, Maphalala, G, Secor, WE, Mejia, R, Orange, JS, Coarfa, C, Bhalla, KN, Graviss, EA, Mandalakas, AM & Makedonas, G 2018, Journal of Immunology, vol. 201, no. 1, pp. 124-133. DOI: 10.4049/jimmunol.1800101

De Novo DSA in the Setting of Stable Renal Allograft Function is a Benign Finding
Knight, RJ, Eagar, TN, Nguyen, DTM, Graviss, EA, Kuten, SA, Patel, SJ, Moore, LW & Gaber, AO 2018, 27th International Congress of The Transplantation Society, Madrid, Spain, 6/30/18 - 7/5/18, .

Clinical and pathologic outcomes of incidental IgA glomerular deposits (IgAGD) in donated kidneys in an ethnically diverse region of the USA
Gaber, LW, Khan, F, Barrios, R, Truong, L, Graviss, E, Nguyen, DTM & Suki, W 2018, Transplantation, vol. 102.

Ciprofloxacin for BK Viremia Prophylaxis in Kidney Transplant Recipients: Results of a Prospective, Randomized Controlled Trial
Patel, SJ, Nguyen, DTM, Graviss, EA, Nolte, JV, Agboli, I, Moore, LW, Kuten, SA, Pham, C, Gaber, AO & Knight, RJ 2018, 2018 American Transplant Congress (ATC), Seattle, United States, 6/2/18 - 6/6/18, .

Prevalence of Metabolic Syndrome (MetS) and Insulin Resistance in Living Kidney Donors
Agboli, I, Moore, LW, Nguyen, DTM, Graviss, EA, Ibrahim, H, Gaber, AO & Sadhu, A 2018, 2018 American Transplant Congress (ATC), Seattle, United States, 6/2/18 - 6/6/18, .